Skip to content
healthcare.dev

Orphenadrine Citrate

NDC 50090-0169, ORPHENADRINE CITRATE, tablet, extended release, from A-S Medication Solutions.

Product NDC
50090-0169
Status
Listed
Labeler
A-S Medication Solutions
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040284
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50090-0169 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ORPHENADRINE CITRATE100 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
50090-0169-05009001690020 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-0169-0)
50090-0169-15009001690130 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-0169-1)
50090-0169-55009001690560 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-0169-5)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/80ef7fb4-7c50-4d25-915e-f9d4a2ccd199

Use it

Look up 50090-0169 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50090-0169 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50090-0169. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.